Who Owns PHAR?

Pharming Group N.V. — Institutional Ownership & 13F Holdings

$16.35

-0.57 (-3.37%)

Market Cap

$1.1B

Shares Outstanding

66,333,701

Institutional Holders

3

Total Inst. Value

$425K

% of Float Held

0.1%

QoQ Holder Change

Institutional data as of Q1 2025

New Positions

2

Closed Positions

4

Increased

1

Decreased

0

Institutional Ownership Trend

Top 10 Institutional Holders(Q1 2025)

#FundValueShares
1Silverberg Bernstein Capital Management LLCNew$402K47,997
2MORGAN STANLEY$23K2,900
3COLDSTREAM CAPITAL MANAGEMENT INCNew$887106

Biggest Buyers & Sellers This Quarter

Top Buyers

Top Sellers

FundShares RemovedValue

Related Stocks

Frequently Asked Questions

How many institutional investors hold PHAR?

As of Q1 2025, 3 institutional investors report holding PHAR (Pharming Group N.V.) in their 13F filings.

What percentage of Pharming Group N.V. is owned by institutions?

Institutional investors hold approximately 0.1% of Pharming Group N.V.'s float as reported in SEC 13F filings.

Which hedge fund owns the most PHAR?

The largest institutional holder of PHAR is Silverberg Bernstein Capital Management LLC with $402K in shares.

Are institutions buying or selling PHAR?

This quarter, 2 institutions opened new positions in PHAR and 4 closed their positions.

What is 13F institutional ownership?

SEC Form 13F is a quarterly report filed by institutional investment managers with over $100M in qualifying assets. It discloses their US equity holdings, providing transparency into what the largest investors are buying and selling.

How often is institutional ownership data updated?

13F filings are due 45 days after each calendar quarter end (May 15, Aug 14, Nov 14, Feb 14). Data is updated on HedgeTrace as new filings are processed.